“I must, and I can live with that”: a thematic analysis of patients’ perspectives on polypharmacy and a digital decision support system for GPs
Robin Brünn(Goethe University Frankfurt), Simone Grandt, Mathias Flume(Landschaftsverband Westfalen-Lippe), Nina Timmesfeld(Zimmer Biomet (Germany)), Sara Söling(University of Cologne), Renate Klaaßen‐Mielke(Zimmer Biomet (Germany)), Hans J. Trampisch(Heidelberg University), Frank Meyer(National Association of Statutory Health Insurance Physicians), Benjamin Brandt(University of California San Diego), Till Beckmann(BARMER GEK), Ute Karbach(TU Dortmund University), Beate S. Müller(Goethe University Frankfurt), Ana Isabel González‐González(Goethe University Frankfurt), Truc Sophia Dinh(Goethe University Frankfurt), Kiran Chapidi, Thomas Müller(Ruhr University Bochum), Reinhard Hammerschmidt(National Association of Statutory Health Insurance Physicians), Lara Düvel(BARMER GEK), Johanna Richard, Marjan van den Akker(Maastricht University), Alexandra Piotrowski(University of Wuppertal), Karolina Beifuß, Sarah L. Meyer(University of Wuppertal), Peter Ihle(University Hospital Cologne), Ferdinand M. Gerlach(Goethe University Frankfurt), Petra Kellermann-Mühlhoff(BARMER GEK), Bastian Surmann(Bielefeld University), Juliane Köberlein–Neu(University of Wuppertal), Daniel Grandt(Klinikum Saarbrücken), Holger Pfaff(University of Cologne), Ingo Meyer(University of Cologne), Eva Leicher, Christiane Muth(Bielefeld University), Jale Basten, Wolfgang Greiner(Bielefeld University), Benno Flaig(Goethe University Frankfurt), Julia Jachmich
Cited by 8
Related Papers
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
|New England Journal of Medicine|1985|1.1k
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
|Atherosclerosis|2003|824
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618